"The extreme complexities of the legal system underpinning the grant and validity of SPCs is highlighted by the wealth of case law originating from appeals from national patent offices. Those complexities, and the commercial importance of rights afforded by SPCs, are also giving rise to an increased number of disputes in which the validity of SPCs are being challenged independently of the validity of the underlying patent and that trend is likely to continue".
"Pediatric Exclusivities in Europe -- a Quest for the Grail?", an article by Geneviève Michaux (of Counsel. Covington & Burling LLC, Brussels, Belgium), originally published in 64 Food and Drug Law Journal, 631-662 (2009), has now been republished in issue 1 (2010) of the respected Intellectual Property Quarterly (IPQ), a journal which is associated with the Intellectual Property Institute, London. For the abstract of this article (nb the IPQ does not publish abstracts) click here.